| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | VACCINE COMPANY INC | 10421 MOTOR CITY DR WESTLAKE #34416 | BETHESDA | MD | 20817-9996 | MONTGOMERY | USA | AY2AX000054 | Project A-FAVE: Applied biotechnology for broad Flavivirus Antigen discovery and Vaccine candidate Evaluation | 000 | 1 | NIH | 6/24/2025 | $0 |
| | 2025 | 2024 | VACCINE COMPANY INC | 10421 MOTOR CITY DR WESTLAKE #34416 | BETHESDA | MD | 20817-9996 | MONTGOMERY | USA | AY2AX000054 | Project A-FAVE: Applied biotechnology for broad Flavivirus Antigen discovery and Vaccine candidate Evaluation | 001 | 1 | NIH | 7/2/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $28,179,321 ) |
| | 2024 | 2024 | VACCINE COMPANY INC | 10421 MOTOR CITY DR WESTLAKE #34416 | BETHESDA | MD | 20817-9996 | MONTGOMERY | USA | AY2AX000054 | Project A-FAVE: Applied biotechnology for broad Flavivirus Antigen discovery and Vaccine candidate Evaluation | 000 | 1 | NIH | 9/21/2024 | $28,179,321 |
|
|
